← Back to Search

Ablation Device

Intramural Needle Ablation Catheter for Ventricular Tachycardia

N/A
Waitlist Available
Led By Usha Tedrow, M.D.
Research Sponsored by William Stevenson
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This study is evaluating whether a new device called an Intramural Needle Ablation Catheter (INA catheter) can help people who have ventricular arrhythmias that have failed standard radiofrequency ablation.

Eligible Conditions
  • Ventricular Tachycardia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With No Serious Adverse Events
Number of Subjects Ablated for Nonsustained Arrhythmias Who Had a Reduction to Less Than 5000 Arrhythmia Beats Daily
Number of Subjects Without Hospitalization for Ventricular Tachycardia (VT) During 6 Months
Secondary outcome measures
Number of Subjects With Acute Abolition of at Least One Clinical Inducible Ventricular Tachycardia or Targeted Nonsustained Arrhythmia

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intramural Needle Catheter AblationExperimental Treatment1 Intervention
Ablation of Ventricular Tachycardia with Intramural Needle Ablation Catheter
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intramural Needle Ablation Catheter
2016
N/A
~120

Find a Location

Who is running the clinical trial?

William StevensonLead Sponsor
William G. Stevenson, M.D.Study DirectorVanderbilt Heart and Vascular Institute
Usha Tedrow, M.D.Principal InvestigatorBrigham and Women's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
William Stevenson 2016. "Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01791543.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top